🚀 VC round data is live in beta, check it out!
Nuwellis Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nuwellis and similar public comparables like Profusa, Monivent, PExA, SpectraCure and more.
Nuwellis Overview
About Nuwellis
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Founded
2002
HQ
Employees
38
Website
Sectors
Financials (LTM)
EV
$2M
Nuwellis Financials
Nuwellis reported last 12-month revenue of $8M.
In the same LTM period, Nuwellis generated $5M in gross profit and had net loss of ($15M).
Revenue (LTM)
Nuwellis P&L
In the most recent fiscal year, Nuwellis reported revenue of $8M and EBITDA of ($7M).
Nuwellis expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $8M | XXX | $8M | XXX | XXX | XXX |
| Gross Profit | $5M | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($7M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (79%) | XXX | XXX | XXX |
| EBIT Margin | (126%) | XXX | (134%) | XXX | XXX | XXX |
| Net Profit | ($15M) | XXX | ($18M) | XXX | XXX | XXX |
| Net Margin | (179%) | XXX | (212%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nuwellis Stock Performance
Nuwellis has current market cap of $3M, and enterprise value of $2M.
Market Cap Evolution
Nuwellis' stock price is $1.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $3M | 0.0% | XXX | XXX | XXX | $-6.65 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNuwellis Valuation Multiples
Nuwellis trades at 0.3x EV/Revenue multiple, and (0.3x) EV/EBITDA.
EV / Revenue (LTM)
Nuwellis Financial Valuation Multiples
As of April 20, 2026, Nuwellis has market cap of $3M and EV of $2M.
Equity research analysts estimate Nuwellis' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nuwellis has a P/E ratio of (0.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.3x) | XXX | XXX | XXX |
| EV/EBIT | (0.2x) | XXX | (0.2x) | XXX | XXX | XXX |
| EV/Gross Profit | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| P/E | (0.2x) | XXX | (0.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nuwellis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nuwellis Margins & Growth Rates
Nuwellis' revenue in the last 12 month grew by 12%.
Nuwellis' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Nuwellis Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (79%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 34% | XXX | 33% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 196% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nuwellis Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| Profusa | XXX | XXX | XXX | XXX | XXX | XXX |
| Monivent | XXX | XXX | XXX | XXX | XXX | XXX |
| PExA | XXX | XXX | XXX | XXX | XXX | XXX |
| SpectraCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Massmedica | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nuwellis M&A Activity
Nuwellis acquired XXX companies to date.
Last acquisition by Nuwellis was on XXXXXXXX, XXXXX. Nuwellis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nuwellis
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNuwellis Investment Activity
Nuwellis invested in XXX companies to date.
Nuwellis made its latest investment on XXXXXXXX, XXXXX. Nuwellis invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nuwellis
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nuwellis
| When was Nuwellis founded? | Nuwellis was founded in 2002. |
| Where is Nuwellis headquartered? | Nuwellis is headquartered in United States. |
| How many employees does Nuwellis have? | As of today, Nuwellis has over 38 employees. |
| Who is the CEO of Nuwellis? | Nuwellis' CEO is John L. Erb. |
| Is Nuwellis publicly listed? | Yes, Nuwellis is a public company listed on Nasdaq. |
| What is the stock symbol of Nuwellis? | Nuwellis trades under NUWE ticker. |
| When did Nuwellis go public? | Nuwellis went public in 2012. |
| Who are competitors of Nuwellis? | Nuwellis main competitors are Profusa, Monivent, PExA, SpectraCure. |
| What is the current market cap of Nuwellis? | Nuwellis' current market cap is $3M. |
| What is the current revenue of Nuwellis? | Nuwellis' last 12 months revenue is $8M. |
| What is the current revenue growth of Nuwellis? | Nuwellis revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Nuwellis? | Current revenue multiple of Nuwellis is 0.3x. |
| Is Nuwellis profitable? | No, Nuwellis is not profitable. |
| What is the current net income of Nuwellis? | Nuwellis' last 12 months net income is ($15M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.